Intralipid

Soya Oil, Purified, the active ingredient in Intralipid, is a intravenous lipid emulsion presented as an emulsion for intravenous infusion for patients requiring parenteral nutrition. It provides calories, essential fatty acids, and phospholipids when administered intravenously, supporting energy needs and cell membrane synthesis.\nGNH India supplies Intralipid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Intralipid is used in clinical nutrition to deliver lipid calories and essential fatty acids for patients who cannot receive enteral feeding.\n\nParenteral nutrition: supplies calories and essential fatty acids for patients on total parenteral nutrition.\nEssential fatty acid deficiency: prevents and treats deficiency in long‑term lipid‑restricted diets.\nPatients unable to receive enteral feeding: provides necessary energy and membrane components when oral or tube feeding is not possible.

Intralipid may be associated with a range of adverse reactions following intravenous administration.\n\nCommon Side Effects:\n- Hypertriglyceridemia: elevated blood triglyceride levels.\n- Fever or chills: transient temperature rise during infusion.\n- Infusion site irritation: redness or discomfort at the catheter site.\n- Nausea or vomiting: gastrointestinal upset.\n- Lipemia: milky appearance of blood samples.\n- Respiratory distress: mild dyspnea during rapid infusion.\n\nSerious or Rare Side Effects:\n- Fat overload syndrome: severe metabolic disturbance from excess lipids.\n- Pancreatitis: inflammation of the pancreas due to high triglycerides.\n- Anaphylactic reaction: severe allergic response requiring emergency care.\n- Pulmonary embolism: lipid particles obstructing pulmonary vessels.\n- Hepatic dysfunction: liver enzyme elevations or steatosis.\n- Coagulopathy: bleeding abnormalities related to lipid interference with clotting factors.

When using Intralipid, clinicians should observe several safety measures to minimize risks.\n\nMonitor triglyceride levels: check serum triglycerides regularly during therapy.\nAssess for lipid intolerance: watch for signs of hypersensitivity or fat overload.\nUse caution in pancreatitis: avoid or limit use in patients with active pancreatic inflammation.\nAvoid in soy allergy: contraindicated for patients with known soy or soy oil hypersensitivity.\nAdjust in hepatic dysfunction: reduce dosage or monitor liver function tests closely.\nStore at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intralipid can interact with other medications, influencing efficacy or safety.\n\nMajor Interactions (Avoid):\n- Co‑administration with other lipid emulsions: may cause excessive lipid load.\n- Concurrent use with propofol: both are lipid‑based, increasing risk of fat overload syndrome.\n\nModerate Interactions (Monitor Closely):\n- Anticoagulants (e.g., warfarin): lipid infusion may alter INR levels.\n- Fibrates (e.g., gemfibrozil): combined effect may raise triglyceride concentrations.\n- High‑dose vitamin E: may affect coagulation parameters when given with lipid emulsions.